Harpoon Therapeutics Inc
(HARP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,724 | -49,908 | -38,551 | -25,244 | -12,552 |
| Depreciation Amortization | 1,123 | 2,573 | 1,800 | 1,145 | 563 |
| Accounts payable and accrued liabilities | 1,070 | -1,228 | -815 | -1,032 | -1,090 |
| Other Working Capital | 40,363 | 33,427 | 39,461 | 41,910 | -6,473 |
| Other Operating Activity | 1,091 | 6,520 | 4,656 | 3,259 | 2,035 |
| Operating Cash Flow | $-18,077 | $-8,616 | $6,551 | $20,038 | $-17,517 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -39,855 | -62,943 | -73,446 | -74,247 | -35,311 |
| PPE Investments | -45 | -683 | -625 | -155 | -5 |
| Investing Cash Flow | $-39,900 | $-63,626 | $-74,071 | $-74,402 | $-35,316 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 561 | 1,644 | 1,435 | 687 | 340 |
| Other Financing Activity | 107,581 | 3,032 | 0 | -321 | -75 |
| Financing Cash Flow | $108,142 | $4,676 | $1,435 | $366 | $265 |
| Beginning Cash Position | 21,637 | 89,203 | 89,203 | 89,203 | 89,203 |
| End Cash Position | 71,802 | 21,637 | 23,118 | 35,205 | 36,635 |
| Net Cash Flow | $50,165 | $-67,566 | $-66,085 | $-53,998 | $-52,568 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,077 | -8,616 | 6,551 | 20,038 | -17,517 |
| Capital Expenditure | -45 | -683 | -625 | -155 | -5 |
| Free Cash Flow | -18,122 | -9,299 | 5,926 | 19,883 | -17,522 |